“…Other nation-wide series, however, reported percentages as low as 4% [ 43 ], and a recent systematic review demonstrated a pooled prevalence of 15.4% [ 51 ], suggesting that there are many factors contributing to the development of HCC [ 41 ]. Serum alpha fetoprotein (AFP) levels have a role in the differential diagnosis between HCC and regenerative nodules [ 15 , 16 , 17 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]. As radiological features of hepatocellular nodules arising in the context of vascular liver diseases, including BCS are less characteristic, their diagnosis remains challenging, and may require liver biopsy in the end [ 7 ]; however, histologically, HCC nodules in BCS are very-well to well-differentiated hepatocellular proliferations without vascular invasion, leading to a challenging diagnosis with benign proliferations even on pathology [ 15 ].…”